Interestingly, in the early days of PSA testing, African American (AA) men with newly diagnosed prostate cancer had higher serum PSA levels at initial diagnosis than Caucasian American (CA) men, which corresponded to a larger tumor volume observed in AA men treated in an equal access health care system [14] . The gene discussed is KLK3; the disease is prostate cancer.